Physician profile
Preslee Magee
NPI 1023460326
$1,183.96
in general payments reported to CMS, 2019-2025
17 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $33.54 · 2021: $164 · 2022: $210 · 2023: $156 · 2024: $186 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $209.29 | 2022-2025 | Rocklatan, Precision 1, Argos |
| Abbvie INC. | $191.41 | 2022-2025 | |
| Glaukos Corporation | $97.66 | 2021-2025 | Idosetr |
| Optos, INC. | $90.92 | 2019 | |
| Sun Pharmaceutical Industries INC. | $90.34 | 2019-2023 | Cequa |
| Bausch & Lomb Americas INC. | $84.82 | 2022-2025 | Miebo |
| Aerie Pharmaceuticals, INC. | $72.92 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.26 | 2019 | |
| Allergan, INC. | $62.96 | 2019-2021 | |
| Thea Pharma INC. | $49.87 | 2024-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $35.47 | 2019 | |
| Ocular Therapeutix, INC. | $29.58 | 2023 | Dextenza |
| Sight Sciences, INC. | $29.20 | 2021-2022 | |
| Harrow Eye, LLC | $27.65 | 2024 | Iheezo |
| Rxsight INC | $16.15 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $15.88 | 2023 | |
| Biotissue Holdings INC. | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preslee Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.